Supplemental material
Original Articles
Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study#
Josep GamezNeuromuscular Disorders Clinic, Department of Neurology, Vall d’Hebron University Hospital, VHIR, European Reference Network on Rare, Neuromuscular Disorders (ERN EURO-NMD), UAB, Barcelona, Spain; Correspondence[email protected]
http://orcid.org/0000-0003-3127-7486View further author information
http://orcid.org/0000-0003-3127-7486View further author information, María SalvadóNeuromuscular Disorders Clinic, Department of Neurology, Vall d’Hebron University Hospital, VHIR, European Reference Network on Rare, Neuromuscular Disorders (ERN EURO-NMD), UAB, Barcelona, Spain; http://orcid.org/0000-0002-1526-1903View further author information
http://orcid.org/0000-0002-1526-1903View further author information, Núria ReigResearch and Development Department, SOM Biotech, S.L, Barcelona, Spain; http://orcid.org/0000-0001-6927-469XView further author information
http://orcid.org/0000-0001-6927-469XView further author information, Pilar SuñéPharmacy Department, Vall d’Hebron Research Institute (VHIR), Hospital Universitari Vall d’Hebron, Barcelona, Spain; http://orcid.org/0000-0003-2418-7693View further author information
http://orcid.org/0000-0003-2418-7693View further author information, Carles CasasnovasNeuromuscular Disorders Unit, Neurology Department, Bellvitge University Hospital – IDIBELL, Barcelona, Spain; http://orcid.org/0000-0002-7933-4681View further author information
http://orcid.org/0000-0002-7933-4681View further author information, Ricard Rojas-GarciaDepartment of Neurology, Neuromuscular Diseases Unit Hospital de la Santa Creu i Sant Pau, Center for Networked Biomedical Research into Rare Diseases (CIBERER), UAB, Barcelona, Spainhttp://orcid.org/0000-0003-1411-5573View further author information
http://orcid.org/0000-0003-1411-5573View further author information & Raúl InsaResearch and Development Department, SOM Biotech, S.L, Barcelona, Spain; http://orcid.org/0000-0002-6424-2784View further author information
http://orcid.org/0000-0002-6424-2784View further author information show all